Epidemiology and Microbiology of Secondary Peritonitis Caused by Viscus Perforation: A Single-Center Retrospective Study

Surgical Infections

Volumn 16, Issue 4, 2015, Pages 436-442

  Jang, Ji Young ^a   Lee, Seung Hwan ^b   Shim, Hongjin ^a   Choi, Jun Yong ^b   Yong, Dongeun ^b   Lee, Jae Gil ^b  

^a Yonsei University Wonju   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; CORTICOSTEROID; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACILLUS; BACTERIUM IDENTIFICATION; BACTEROIDES; BACTEROIDES FRAGILIS; BLOOD CULTURE; CANDIDA ALBICANS; CHEMOTHERAPY; CLINICAL FEATURE; COLON PERFORATION; COMMUNITY ACQUIRED INFECTION; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; DUODENUM PERFORATION; ENDOCRINE DISEASE; ENTEROBACTER AEROGENES; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYPOTENSION; KLEBSIELLA PNEUMONIAE; LARGE INTESTINE PERFORATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROCOCCUS; MONOTHERAPY; MORTALITY; PERIOPERATIVE PERIOD; PERITONITIS; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECTUM PERFORATION; RETROSPECTIVE STUDY; SEPSIS; SMALL INTESTINE PERFORATION; STAPHYLOCOCCUS EPIDERMIDIS; STOMACH PERFORATION; STREPTOCOCCUS; VISCUS PERFORATION; AGED; BACTERIUM; COMPLICATION; CROSS INFECTION; DRUG EFFECTS; INTESTINAL PERFORATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; PERITONITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84937927914     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2014.148     Document Type: Article

References (29)

1. Weigelt JA. Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med 2007;74(Suppl 4):S29-S37.
2. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intraabdominal infections. Clin Infect Dis 2003;37:997-1005.
3. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 2010;11:79-109.
4. Marshall JC. Intra-abdominal infections. Microb Infect Institut Pasteur 2004;6:1015-1025.
5. Sartelli M, Viale P, Catena F, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2013;8:3.
6. Lee K, Lee MA, Lee CH, et al. Increase of ceftazidime-and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: Analysis of KONSAR study data from 2005 and 2007. Yonsei Med J 2010;51:901-911
7. Lee K, Kim MN, Kim JS, et al. Further Increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009. Yonsei Med J 2011;52:793-802.
8. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
9. American College of Chest Physicians/Society of Critical Care Medicine. Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
10. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16: 128-140.
11. Crowe MJ, Cooke EM. Review of case definitions for nosocomial infection-Towards a consensus. Presentation by the Nosocomial Infection Surveillance Unit (NISU) to the Hospital Infection Liaison Group, Subcommittee of the Federation of Infection Societies (FIS). J Hosp Infect 1998;39:3-11.
12. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial disk susceptibility testing: Nineteenth informational supplement. Wayne, PA. CLSI 2009:M100-S117.
13. Skrupky LP, Tellor BR, Mazuski JE. Current strategies for the treatment of complicated intraabdominal infections. Expert Opin Pharmacol 2013;14:1933-1947.
14. Hau T, Ahrenholz DH, Simmons RL. Secondary bacterial peritonitis: The biological basis of treatment. Curr Probl Surg 1978;16:1-65.
15. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000;49:827-830.
16. FarthmannEH, SchoffelU.Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection 1998;26:329-334
17. Brook I. Microbiology of polymicrobial abscesses and implications for therapy. J Antimicrob Chemother 2002;50: 805-810.
18. Goldstein EJ, Snydman DR. Intra-abdominal infections: Review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. J Antimicrob Chemother 2004;53(Suppl 2):ii29-ii36.
19. Sartelli M, Catena F, Ansaloni L, et al. Complicated intraabdominal infections in a worldwide context: An observational prospective study (CIAOW Study). World J Emerg Surg 2013;8:1.
20. Finegold SM. Microflora of the Gastrointestinal Tract. New York: McGraw-Hill, 1982.
21. Levison ME, Bush LM. Peritonitis and Other Intra-Abdominal Infections. 5th ed. New York: Churchill Livingstone. 2000.
22. Swenson BR, Metzger R, Hedrick TL, et al. Choosing antibiotics for intra-abdominal infections: What do we mean by ''high risk''? Surg Infect 2009;10:29-39.
23. Sotto A, Lefrant JY, Fabbro-Peray P, et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002;50:569-576.
24. Roehrborn A, Thomas L, Potreck O, et al. Themicrobiology of postoperative peritonitis. Clin Infect Dis 2001;33:1513-1519.
25. Sitges-Serra A, Lopez MJ, Girvent M, et al. Postoperative enterococcal infection after treatment of complicated intraabdominal sepsis. Br J Surg 2002;89:361-367.
26. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition of the role of Enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 1995;118:716-721.
27. de Ruiter J, Weel J, Manusama E, et al. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 2009;37: 522-527.
28. Sheng WH, Badal RE, Hsueh PR. Distribution of extendedspectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013;57: 2981-2988.
29. Hsueh PR, Badal RE, Hawser SP, et al. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2010;36:408-414.